Cannabis use disorder is characterized by an inability to stop using marijuana despite negative impacts on personal health, relationships, and responsibilities. Symptoms can range from unsuccessful attempts to quit, increased tolerance, and cravings, to more severe issues such as mood swings, anxiety, and impaired cognitive function. In Maryland, where marijuana was legalized for recreational use in 2023, the rates of reported cannabis-related issues have risen alongside broader access to the drug.
Public health officials point out that legalization, while offering many benefits such as criminal justice reform and economic opportunities, has also made cannabis far more accessible. This ease of access, coupled with a growing social acceptance, may lead some individuals to underestimate the drug’s potential risks. Experts stress that today’s cannabis products are often far more potent than in decades past, increasing the likelihood of dependency and adverse mental health outcomes, especially among younger users.
Healthcare providers are working to address this emerging challenge by promoting awareness, improving screening processes for CUD, and developing treatment options tailored to cannabis-related issues. Maryland’s experience mirrors national trends, underscoring the need for a balanced approach to legalization—one that supports personal freedom while actively addressing public health concerns.
As cannabis continues to weave itself into the cultural and economic fabric of Maryland, a critical eye must remain on its consequences. Thoughtful education campaigns, investment in mental health services, and open discussions about cannabis use are vital steps in ensuring that legalization does not come at the expense of public well-being.
Dabbin-Dad Newsroom
If you liked this post, say thanks by sharing it
